SR
Salveen Richter Goldman Sachs Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
29
Avg Return
Past Year
Past Year
20%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
23.5%
Neutral
58.8%
Negative
17.6%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Financials
Healthcare
Industrials
Technology
Financials
Credit Services
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Medical Care Facilities
Industrials
Farm & Heavy Construction Machinery
Technology
Software - Application
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Neutral
Maintained
| $9 |
66%
downside
| 3 | – |
–
| 3 Mar ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $41 |
10%
downside
| 1 | +7.9% |
–
| 17 Feb ‘26 3 months ago |
|
|
|
Neutral
Maintained
| $25 |
6%
downside
| 1 | – |
–
| 20 Nov ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $11 |
24%
downside
| 2 | – |
–
| 5 Nov ‘25 6 months ago |
|
|
|
Neutral
Maintained
| $16 |
35%
downside
| 2 | – |
–
| 30 Oct ‘25 7 months ago |
|
|
|
Neutral
Upgraded
| $65 |
11%
downside
| 2 | -9.5% |
0
%
| 26 Sep ‘25 8 months ago |
|
|
|
Sell
Downgraded
| $18 |
56%
downside
| 1 | +15% |
0
%
| 26 Sep ‘25 8 months ago |
|
|
|
Buy
Initiated
| $26 |
34%
upside
| 1 | +119% |
0
%
| 22 Sep ‘25 8 months ago |
|
|
|
Buy
Maintained
| $566 |
98%
upside
| 1 | -31% |
0
%
| 16 Sep ‘25 8 months ago |
|
|
|
Buy
Maintained
| $38 |
310%
upside
| 2 | +62% |
0
%
| 12 Aug ‘25 9 months ago |
|
|
|
Neutral
Maintained
| $19 |
17%
upside
| 3 | -55% |
0
%
| 7 Aug ‘25 9 months ago |
|
|
|
Sell
Maintained
| $17 |
19%
downside
| 1 | +10% |
0
%
| 7 Aug ‘25 9 months ago |
|
|
|
Buy
Initiated
| $37 |
4%
upside
| 1 | +26% |
0
%
| 16 Jun ‘25 11 months ago |
|